Allient stock: growth
ALNTAllient reported $554.48M in revenue for fiscal 2025, up 4.6% on the prior year, up 8.6% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2006 | |
|---|---|---|---|
| Revenue | 8.6% | 9.1% | 10.5% |
| Revenue per share | 5.3% | 7.1% | 7.4% |
| Earnings | 10.1% | 7.1% | 13.7% |
| Earnings per share | 6.6% | 5.1% | 10.4% |
| Free cash flow | 26.3% | 12.5% | 17.8% |
| Free cash flow per share | 22.4% | 10.4% | 14.5% |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2006 | $82.77M | $1.93M | $2.21M |
| 2007 | $84.56M | $2.4M | $4.57M |
| 2008 | $85.97M | $2.91M | $4.56M |
| 2009 | $61.24M | −$12.45M | $1.95M |
| 2010 | $80.59M | $3.59M | $5.96M |
| 2011 | $110.94M | $6.97M | $7.03M |
| 2012 | $101.97M | $5.4M | $2.01M |
| 2013 | $125.5M | $3.95M | $7.69M |
| 2014 | $249.68M | $13.86M | $16.25M |
| 2015 | $232.43M | $11.07M | $15.34M |
| 2016 | $245.89M | $9.08M | $9.12M |
| 2017 | $252.01M | $8.04M | $19.21M |
| 2018 | $310.61M | $15.93M | $3.12M |
| 2019 | $371.08M | $17.02M | $19.65M |
| 2020 | $366.69M | $13.64M | $15.47M |
| 2021 | $403.52M | $24.09M | $11.69M |
| 2022 | $502.99M | $17.39M | −$10.31M |
| 2023 | $578.63M | $24.1M | $33.44M |
| 2024 | $529.97M | $13.17M | $32.17M |
| 2025 | $554.48M | $22.03M | $49.69M |
Revenue by segment
How Allient Inc. makes its money and how that has shifted. Names are as the company reports them.
- Industrial48%
- Vehicle17%
- Medical15%
- Aerospace & Defense15%
- Other5%
“Other” combines smaller and former segments with revenue the company does not assign to a segment. Names as reported, with abbreviations spelled out for the largest companies.
Figures as a table
| 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|
| Industrial | $193.29M | $257M | $248.28M | $268.39M | 48.4% |
| Vehicle | $130.44M | $133.49M | $102.7M | $97.02M | 17.5% |
| Medical | $85.11M | $84.52M | $77.96M | $81.69M | 14.7% |
| Aerospace & Defense | $70.19M | $78.18M | $75.18M | $81.34M | 14.7% |
| Other | $23.96M | $25.45M | $25.84M | $26.05M | 4.7% |
| Total revenue | $502.99M | $578.63M | $529.97M | $554.48M | 100% |
Revenue by region
Where Allient Inc. generates its revenue.
- United States67%
- Europe29%
- Asia Pacific4%
Figures as a table
| 2022 | 2023 | 2024 | 2025 | Share 2025 | |
|---|---|---|---|---|---|
| United States | $337.77M | $399.22M | $359.07M | $368.92M | 66.5% |
| Europe | $130.02M | $150.61M | $145.62M | $160.66M | 29% |
| Asia Pacific | $35.2M | $28.8M | $25.28M | $24.9M | 4.5% |
| Total revenue | $502.99M | $578.63M | $529.97M | $554.48M | 100% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Neutral, published since 7 Nov 2026 (in the score history since 18 Apr 2025)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.
